Literature DB >> 12591188

Management of chronic hepatitis B.

Hari S Conjeevaram1, Anna Suk-Fong Lok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12591188     DOI： 10.1016/s0168-8278(02)00431-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  34 in total

1.  Quantifying anti-HBV effect of targeted ribonuclease by real-time fluorescent PCR.

Authors:  Jun Liu; Ying-Hui Li; Jin Ding; Wei-Dong Gong; Cai-Fang Xue; Ya Zhao; Yu-Xiao Huang
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

2.  Cost-effective method of siRNA preparation and its application to inhibit hepatitis B virus replication in HepG2 cells.

Authors:  Zhi-Kang Qian; Bao-Qin Xuan; Tai-Shan Min; Jian-Feng Xu; Lin Li; Wei-Da Huang
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

Review 3.  Peginterferon-alpha-2a (40kD): a review of its use in the management of patients with chronic hepatitis B.

Authors:  Gayle W Robins; Lesley J Scott; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Early reduction of infected hepatocytes by activated immunity at the time of interferon withdrawal hepatitis followed by lamivudine administration resulted in higher seroconversion in hepatitis Be antigen-positive patients with chronic hepatitis B.

Authors:  Michiko Shindo; Kazushige Hamada; Akira Muramatsu; Teruhisa Morikawa; Tadao Okuno
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

5.  Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey.

Authors:  Mustafa Sunbul; Hakan Leblebicioglu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

6.  Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.

Authors:  Teerha Piratvisuth; George Lau; You-Chen Chao; Rui Jin; Anuchit Chutaputti; Q-B Zhang; Tawesak Tanwandee; Peter Button; Matei Popescu
Journal:  Hepatol Int       Date:  2008-02-05       Impact factor: 6.047

7.  Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus.

Authors:  Kang Mo Kim; Won-Beom Choi; Young-Suk Lim; Han-Chu Lee; Young-Hwa Chung; Young-Sang Lee; Dong-Jin Suh
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

8.  Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay.

Authors:  Joseph D C Yao; Marcel G H M Beld; Lynette Lin Ean Oon; Christopher H Sherlock; Jeffrey Germer; Sandra Menting; Su Yun Se Thoe; Linda Merrick; Rainer Ziermann; Johan Surtihadi; H James Hnatyszyn
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

9.  Effect of vector-expressed siRNA on HBV replication in hepatoblastoma cells.

Authors:  Jun Liu; Ying Guo; Cai-Fang Xue; Ying-Hui Li; Yu-Xiao Huang; Jin Ding; Wei-Dong Gong; Ya Zhao
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 10.  Meta-analysis: adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus.

Authors:  En-Qiang Chen; Li-Chun Wang; Jun Lei; Lu Xu; Hong Tang
Journal:  Virol J       Date:  2009-10-09       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.